CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr | ₹24,837 Cr | ₹23,423 Cr |
What is the latest Total Liabilities ratio of CIPLA ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹32,130 Cr |
Mar2023 | ₹29,007 Cr |
Mar2022 | ₹26,652 Cr |
Mar2021 | ₹24,837 Cr |
Mar2020 | ₹23,423 Cr |
How is Total Liabilities of CIPLA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹32,130 Cr | 10.77 | |
Mar2023 | ₹29,007 Cr | 8.83 | |
Mar2022 | ₹26,652 Cr | 7.31 | |
Mar2021 | ₹24,837 Cr | 6.04 | |
Mar2020 | ₹23,423 Cr | - |
Compare Total Liabilities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,667.9 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics | |
MANKIND PHARMA | ₹97,239.7 Cr | 0.2% | -2.4% | 12.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.3% |
1.9% |
2.8% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses